Coronary Artery Disease
Conditions
Interventions
Case series:Nil
Sponsors
Zhongshan Hospital Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 85 years; 2. Patients who agree to receive PCI treatment and have no relevant treatment contraindication; 3. Patients with CTO lesion suggested by coronary angiography, with expected high success rate of surgery and planned to receive stent implantation after vascular patency; 4. Have independent civil capacity, agree to be included in this clinical study and follow-up, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. The patient is allergic to contrast agent and other related drugs; 2. Recent history of bleeding tendency, active gastrointestinal ulcer, cerebral hemorrhage or arachnoid hemorrhage, stroke within half a year, antiplatelet agents and anticoagulant therapy contraindication can not be anticoagulant therapy; 3. Other diseases may affect the life expectancy of less than 12 months; 4. Pregnant or lactating; 5. Patients refuse to participate in the study. 6. Severe liver and kidney dysfunction (ALT > 5 ULN, eGFR 200 mmol/L); 7. Active bleeding; 8. Known bleeding disorders or malignant tumor diseases; 9. Patients with contraindications to the use of antithrombotic drugs; 10. Patients who are not suitable for this study in the opinion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Minimum Stent Area;Stent Plaque Prolapse and Thrombus;Neointimal thickness;Stent thrombosis;Stent malapposition;Effective area;Edge dissection; | — |
Countries
China
Contacts
Public ContactQian Juying
Zhongshan Hospital, Fudan University
Outcome results
None listed